Abbott Laboratories
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
32.7528.5121.3219.43
Price/Sales ratio
5.194.844.524.24
Earnings per Share (EPS)
$4.01$4.61$6.16$6.76

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
29.7214.9540.40208.6153.6241.6543.1835.3227.7633.3534.5841.65
Price/Sales ratio
3.353.242.713.634.154.815.605.794.404.754.834.15
Price/Book Value ratio
3.153.112.753.224.164.935.926.975.244.945.014.16
Price/Cash Flow ratio
18.4722.2917.6617.8620.1525.0224.5623.7120.0826.2822.8520.15
Price/Free Cash Flow ratio
26.1335.6327.1722.4325.8834.1433.9128.8824.6637.7230.7525.88
Price/Earnings Growth ratio
-3.280.15-0.59-2.910.130.781.980.61-36.73-2.05-13.220.78
Dividend Yield
1.97%2.18%2.72%1.85%1.55%1.47%1.31%1.28%1.71%1.86%1.91%1.55%
Profitability Indicator Ratios
Gross Profit Margin
54.47%57.13%56.72%54.95%58.44%58.52%56.64%56.96%56.14%55.18%54.70%58.52%
Operating Profit Margin
12.83%14.05%15.27%6.30%11.93%14.20%15.47%19.55%19.15%16.15%16.73%11.93%
Pretax Profit Margin
12.43%15.59%6.77%8.14%9.39%12.77%14.35%19.06%19.02%16.61%16.44%9.39%
Net Profit Margin
11.28%21.67%6.71%1.74%7.74%11.55%12.98%16.41%15.88%14.26%13.99%7.74%
Effective Tax Rate
31.65%18.12%24.77%84.17%18.76%9.56%10.00%13.88%16.53%14.12%14.91%14.91%
Return on Assets
5.53%10.72%2.65%0.62%3.52%5.43%6.19%9.40%9.31%7.81%7.75%3.52%
Return On Equity
10.61%20.85%6.81%1.54%7.75%11.85%13.71%19.75%18.89%14.82%14.73%7.75%
Return on Capital Employed
8.45%8.94%6.92%2.56%6.27%7.94%8.83%13.56%14.18%10.91%11.59%6.27%
Liquidity Ratios
Current Ratio
1.441.544.022.261.621.441.71N/AN/AN/A1.591.44
Quick Ratio
1.191.253.651.851.201.041.291.451.221.161.141.04
Cash ratio
0.380.542.791.050.420.350.570.740.630.490.500.42
Days of Sales Outstanding
64.6461.1456.8569.9461.8562.0667.6454.9651.9959.7481.4861.85
Days of Inventory outstanding
104.65108.4598.44106.53109.04119.06121.93101.54117.70133.41133.18109.04
Operating Cycle
169.29169.59155.30176.48170.90181.12189.58156.51169.69193.15214.66170.90
Days of Payables Outstanding
42.1345.1047.6471.0685.4689.7196.0086.7987.8487.2178.8689.71
Cash Conversion Cycle
127.16124.48107.65105.4285.4491.4193.5869.7181.85105.93135.8085.44
Debt Ratios
Debt Ratio
0.180.210.410.360.290.260.250.240.220.200.200.26
Debt Equity Ratio
0.360.421.070.900.640.580.570.500.450.380.370.58
Long-term Debt to Capitalization
0.130.210.500.460.380.340.360.320.280.260.240.34
Total Debt to Capitalization
0.260.290.510.470.390.360.360.330.310.270.270.36
Interest Coverage Ratio
17.3217.587.381.904.416.769.81N/AN/AN/A13.904.41
Cash Flow to Debt Ratio
0.460.320.140.190.320.330.420.580.570.490.580.32
Company Equity Multiplier
1.911.942.562.462.202.182.212.102.021.891.862.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.180.140.150.200.200.190.220.240.210.180.210.20
Free Cash Flow / Operating Cash Flow Ratio
0.700.620.650.790.770.730.720.820.810.690.740.73
Cash Flow Coverage Ratio
0.460.320.140.190.320.330.420.580.570.490.580.32
Short Term Coverage Ratio
0.820.942.417.8030.434.1535.9113.964.256.724.054.15
Dividend Payout Ratio
58.75%32.62%109.92%387.63%83.36%61.56%56.95%45.28%47.72%62.13%65.30%65.30%